Literature DB >> 1426420

H-2 influence on ankylosing enthesopathy of the ankle (ANKENT).

J Capková1, P Ivanyi.   

Abstract

Joint disease, ankylosing enthesopathy (ANKENT) of the ankle, occurs naturally in mice. ANKENT depends on the genetical constitution, sex, and age, and its frequency varies among inbred strains of normal mice. We found the highest frequency of ANKENT in B10.BR (H-2k) males. The H-2k haplotype appears to be a relative risk factor, which increases the susceptibility to ANKENT. The aetiology of ANKENT is unknown but an involvement of microbial agents in the environment is supposed.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1426420

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN： 0015-5500            Impact factor:   0.906


  5 in total

1.  Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice.

Authors:  J Capkova; P Ivanyi; Z Rehakova
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

2.  Experimental colitis does not increase the prevalence of ANKENT, a spontaneous joint disease in mice.

Authors:  J Capková; R Stepánková; T Hudcovic; J Sinkora; Z Reháková
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

3.  Lipopolysaccharide treatment suppresses spontaneously developing ankylosing enthesopathy in B10.BR male mice: the potential role of interleukin-10.

Authors:  Jana Capkova; Tomas Hrncir; Alena Kubatova; Helena Tlaskalova-Hogenova
Journal:  BMC Musculoskelet Disord       Date:  2012-06-21       Impact factor: 2.362

Review 4.  Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B*27 Connection.

Authors:  Chengappa G Kavadichanda; Jie Geng; Sree Nethra Bulusu; Vir Singh Negi; Malini Raghavan
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

5.  Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors.

Authors:  Katelin R Haynes; Allison R Pettit; Ran Duan; Hsu-Wen Tseng; Tibor T Glant; Matthew A Brown; Gethin P Thomas
Journal:  Arthritis Res Ther       Date:  2012-11-22       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.